Inge Wijnbergen

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Michael Haude, Raimund Erbel, Paul Erné et al. · The Lancet · 2013 · 419 citations

Percutaneous Coronary Intervention, Engineering, De-novo Coronary Lesions +5

Novel monorail infusion catheter for volumetric coronary blood flow measurement in humans: in vitro validation

Marcel van ’t Veer, Julien Adjedj, Inge Wijnbergen et al. · EuroIntervention · 2016 · 95 citations · Full text

Gender differences in long‐term outcome after primary percutaneous intervention for ST‐segment elevation myocardial infarction

Inge Wijnbergen, Jan G.P. Tijssen, Marcel van ’t Veer et al. · Catheterization and Cardiovascular Interventions · 2013 · 75 citations

Pressure gradient vs. flow relationships to characterize the physiology of a severely stenotic aortic valve before and after transcatheter valve implantation

Nils P. Johnson, Jo M. Zelis, Pim A.L. Tonino et al. · European Heart Journal · 2018 · 48 citations · Full text

Safety of absolute coronary flow and microvascular resistance measurements by thermodilution

Danielle Keulards, Marcel van ’t Veer, Jo M. Zelis et al. · EuroIntervention · 2021 · 43 citations · Full text